Piramal Pharma Limited (PPLPHARMA.BO)
INR 221.45
(2.07%)
INR 221.45
(2.07%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 19.91 Billion INR | -48.75% |
| 2022 | 38.85 Billion INR | 18.26% |
| 2021 | 32.85 Billion INR | 178.42% |
| 2020 | 11.79 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 12.95 Billion INR | 10.47% |
| 2024 Q1 | 4.92 Billion INR | -4.14% |
| 2023 Q1 | 11.63 Billion INR | 88.99% |
| 2023 FY | 19.91 Billion INR | -48.75% |
| 2023 Q4 | 5.13 Billion INR | -57.22% |
| 2023 Q3 | 12.01 Billion INR | 0.74% |
| 2023 Q2 | 11.92 Billion INR | 2.5% |
| 2022 Q2 | 10.49 Billion INR | -0.24% |
| 2022 Q1 | 10.52 Billion INR | 174.75% |
| 2022 FY | 38.85 Billion INR | 18.26% |
| 2022 Q4 | 6.15 Billion INR | -47.28% |
| 2022 Q3 | 11.67 Billion INR | 11.25% |
| 2021 Q2 | 9.13 Billion INR | 0.0% |
| 2021 FY | 32.85 Billion INR | 178.42% |
| 2021 Q4 | -14.07 Billion INR | -254.14% |
| 2021 Q3 | 9.13 Billion INR | 0.03% |
| 2020 FY | 11.79 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | -25.484% |
| Aurobindo Pharma Limited | 39.23 Billion INR | 49.245% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -71.072% |
| Granules India Limited | 7.18 Billion INR | -177.262% |
| Indoco Remedies Limited | 4.74 Billion INR | -319.351% |
| Achyut Healthcare Limited | 1.6 Million INR | -1237563.145% |
| Ajanta Pharma Limited | 30.46 Billion INR | 34.628% |
| Alkem Laboratories Limited | 32.83 Billion INR | 39.351% |
| Alpa Laboratories Limited | 156.14 Million INR | -12653.367% |
| Brooks Laboratories Limited | 51.18 Million INR | -38809.73% |
| AstraZeneca Pharma India Limited | 2.6 Billion INR | -665.805% |
| Bajaj HealthCare Limited | 985.34 Million INR | -1921.018% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -1303.163% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 79.23% |
| Eris Lifesciences Limited | 4.94 Billion INR | -302.878% |
| FDC Limited | 5.34 Billion INR | -272.327% |
| Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 70.526% |
| Gufic Biosciences Limited | 1.07 Billion INR | -1747.805% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -837.489% |
| Ipca Laboratories Limited | 13.91 Billion INR | -43.113% |
| Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -2474.831% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -43044.987% |
| Lasa Supergenerics Limited | 291.17 Million INR | -6739.21% |
| Laurus Labs Limited | 3.01 Billion INR | -561.419% |
| Lupin Limited | 95.67 Billion INR | 79.185% |
| Mankind Pharma Limited | 23.15 Billion INR | 13.989% |
| Medicamen Biotech Limited | 335.16 Million INR | -5841.516% |
| Medico Remedies Limited | 161.84 Million INR | -12204.441% |
| Megasoft Limited | 49.52 Million INR | -40107.56% |
| NATCO Pharma Limited | 10.05 Billion INR | -97.992% |
| RPG Life Sciences Limited | 1.63 Billion INR | -1117.609% |
| Sigachi Industries Limited | 579.88 Million INR | -3334.117% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 87.084% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -1319.601% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -2013.118% |
| Unichem Laboratories Limited | 6.72 Billion INR | -196.081% |
| Wanbury Limited | 1.16 Billion INR | -1615.353% |
| Windlas Biotech Limited | 1 Billion INR | -1878.52% |
| ZIM Laboratories Limited | 1.01 Billion INR | -1865.731% |
| Zydus Lifesciences Limited | 43.17 Billion INR | 53.875% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -547.231% |
| Divi's Laboratories Limited | 14.17 Billion INR | -40.536% |
| Hester Biosciences Limited | 908.84 Million INR | -2091.145% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -564.819% |
| Amrutanjan Health Care Limited | 1.09 Billion INR | -1712.031% |
| Bal Pharma Limited | 389.89 Million INR | -5007.594% |
| Strides Pharma Science Limited | 9.16 Billion INR | -117.347% |
| Venus Remedies Limited | 1.91 Billion INR | -939.199% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -547.736% |
| Nectar Lifesciences Limited | 625.55 Million INR | -3083.439% |
| Shilpa Medicare Limited | 2.18 Billion INR | -813.239% |
| Aarti Drugs Limited | 1.16 Billion INR | -1605.727% |
| IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -1712.341% |
| Suven Life Sciences Limited | 109.75 Million INR | -18044.875% |
| Ind-Swift Limited | 946.56 Million INR | -2003.813% |
| Valiant Laboratories Limited | 36.28 Million INR | -54776.133% |
| J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | -136.59% |
| Solara Active Pharma Sciences Limited | 4.57 Billion INR | -334.832% |
| Themis Medicare Limited | 782.85 Million INR | -2443.766% |
| Hikal Limited | 2.48 Billion INR | -700.936% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 7.04% |
| Sequent Scientific Limited | 2.9 Billion INR | -586.261% |
| Novartis India Limited | 470.1 Million INR | -4136.12% |
| Wockhardt Limited | 6.4 Billion INR | -211.156% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -37.775% |
| Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -122752.374% |
| Neuland Laboratories Limited | 2.92 Billion INR | -579.718% |
| Morepen Laboratories Limited | 1.98 Billion INR | -901.987% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -4728.491% |
| Mangalam Drugs & Organics Limited | 676.14 Million INR | -2845.218% |